Michal Besser, PhD, is a global expert in immunology, cell therapy, and translational medicine, boasting an 18-year career spanning both academia and industry. Michal serves as Chief Technology Officer at the Davidoff Comprehensive Cancer Center, Rabin Medical Center, and as an Assistant Professor at the Department of Clinical Immunology and Microbiology at Tel-Aviv University, Israel.
She earned her undergraduate degree and PhD from the Ludwig Maximillian University in Munich, Germany, and completed her postdoctoral research at the Weizmann Institute of Science in Rehovot, Israel.
With extensive experience in early-stage innovation, process development, and IND submissions, Michal has contributed to the development of a wide range of cell and gene therapies. Her supervisory role in the manufacture of over 500 cellular infusion products, including CAR T cells and Tumor Infiltrating Lymphocytes, further underscores her expertise in the field. Michal also serves as a scientific advisory board member and consultant for several global industry partners and is the author of nearly 100 peer-reviewed papers in her field.